Professional Documents
Culture Documents
Enzymes: D. F. Palacio
Enzymes: D. F. Palacio
D. F. Palacio
ENZYMES
Biological catalyst Named after the reaction or reactions they catalyze KINDS OF ENZYMES
1. Oxidoreductases: oxidation-reduction reactions. 2. ransferases: group transfer reactions.
3. Hydrolases: hydrolysis reactions. 4. Lyases: addition of groups to a double bond, or removal of groups to create a double bond. 5. Isomerases: isomerization reactions. 6. Ligases: the joining to two molecules.
Apoenzyme: the protein part of an enzyme. Coenzyme: a nonprotein organic molecule, frequently a B vitamin, that acts as a cofactor. Activation: process that increases the action of an enzyme Inhibition: process that makes an enzyme inactive
Competitive inhibition: binds to the active site of the enzyme surface preventing the binding of substrate Non-competitive inhibitors: binds to other portion of the enzyme surface
Enzyme Concentration
The effect of enzyme concentration on the rate of an enzyme-catalyzed reaction. Substrate concentration, temperature, and pH are constant.
Substrate Concentration
The effect of substrate concentration on the rate of an enzyme-catalyzed reaction. Enzyme concentration, temperature, and pH are constant.
Temperature
The effect of temperature on the rate of an enzymecatalyzed reaction. Substrate and enzyme concentrations and pH are constant.
pH
The effect of pH on the rate of an enzymecatalyzed reaction. Substrate and enzyme concentrations and temperature are constant.
2. Induced-Fit Model
The active site becomes modified to accommodate the substrate.
ENZYME INHIBITION
1. REVERSIBLE INHIBITION - Enzymes regain activity when the inhibitor dissociates from the enzyme a. COMPETITIVE INHIBITION - The inhibitor fits into the active site the same way the substrate, preventing the substrate from entering
Competitive Inhibition
2. Noncompetitive Inhibition -the inhibitor binds to a site other than the active site. The substrate cannot fit in the active site
Noncompetitive Inhibition
Irreversible Inhibition
-caused by molecules that causes an enzyme to lose its activity Examples: 1. Insecticides and nerve gases 2. Antibiotics
1. ENZYME REGULATION
a. Proenzyme (zymogen): an inactive form of an enzyme
that must have part of its polypeptide chain hydrolyzed and removed before it becomes active.
An example is trypsin, a digestive enzyme. It is synthesized and stored as trypsinogen, which has no enzyme activity. It becomes active only after a six-amino acid fragment is hydrolyzed and removed from the N-terminal end of its chain. Removal of this small fragment changes in not only the primary structure but also the tertiary structure, allowing the molecule to achieve its active form
2. FEEDBACK CONTROL
the product of a series of enzyme-catalyzed reactions inhibits an earlier reaction in the sequence.
fe edback inhibition E1 E2 E3 A B C D The inhibition may be competitive or noncompetitive.
3.Allosterism
A regulation process that takes place at a site other than the active site but eventually affects the active site. An enzyme regulated by this mechanism is called an allosteric enzyme. Allosteric enzymes often have multiple polypeptide chains. REGULATOR- the substance that binds to the allosteric enzyme
Types of regulator 1. Positive regulator- speeds the rxn by changing the shape of the active site 2. Negative regulator- slows down rxn by preventing proper binding of a substrate
D. PROTEIN MODIFICATION
Protein modification: the process of affecting enzyme activity by covalently modifying it.
The best known examples of protein modification involve phosphorylation/dephosphorylation. Example: pyruvate kinase (PK) is the active form of the enzyme; it is inactivated by phosphorylation to pyruvate kinase phosphate (PKP)
ATP active PK phos phatase Pi H2 O AD P inactive PKP
k inase
E. ISOENZYME
Isoenzyme: an enzyme that occurs in multiple forms; each catalyzes the same reaction. Example: lactate dehydrogenase (LDH) catalyzes the oxidation of lactate to pyruvate. The enzyme is a tetramer of H and M chains. H4 is present predominately in heart muscle. M4 is present predominantly in the liver and in skeletal muscle. H3M, H2M2, and HM3 also exist. H4 is allosterically inhibited by high levels of pyruvate while M4 is not. H4 in serum correlates with the severity of heart attack.
Serum Serum Serum As partate aminotransferase (AST) Serum, Cereb rosp in al fluid Lactate dehydrogenas e (LD H) Serum Creatin e phosph ok inase (CK) Serum Ph os phohexose isomeras e (PHI) Serum
MULTIPLE CHOICE,STRICTLY NO ERASURES,WRITE THE LETTER OF YOUR CHOICE IN I/2 SHEET OF PAPER.
YOU ARE ONLY GIVEN ONE FULL MINUTE TO READ AND ANSWER EACH QUESTION.